Health CanadaGeneral Alert
VOTRIENT (pazopanib hydrochloride) - Important Change to Frequency of Liver Test...
Published: August 9, 2013Recall ID: 50023Category: generalCountry: Canada
Reason for Recall / Hazard
Product safety
Product Description & Identification
VOTRIENT (pazopanib hydrochloride) - Important Change to Frequency of Liver Test Monitoring - For the Public
Additional Source Details
| Field | Value |
|---|---|
| N I D | 50023 |
| U R L | https://recalls-rappels.canada.ca/en/alert-recall/votrient-pazopanib-hydrochloride-important-change-frequency-liver-test-monitoring-0 |
| Issue | Product safety |
| Title | VOTRIENT (pazopanib hydrochloride) - Important Change to Frequency of Liver Test Monitoring - For the Public |
| Archived | 1 |
| Category | Drugs |
| Last updated | 2013-08-09 |
| Organization | Marketed health products |